These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 497801)

  • 1. Altered chromatin conformation in Alzheimer's disease.
    Crapper DR; Quittkat S; de Boni U
    Brain; 1979 Sep; 102(3):483-95. PubMed ID: 497801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranuclear aluminum content in Alzheimer's disease, dialysis encephalopathy, and experimental aluminum encephalopathy.
    Crapper DR; Quittkat S; Krishnan SS; Dalton AJ; De Boni U
    Acta Neuropathol; 1980; 50(1):19-24. PubMed ID: 7376825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in chromatin structure associated with Alzheimer's disease.
    Lewis PN; Lukiw WJ; De Boni U; McLachlan DR
    J Neurochem; 1981 Nov; 37(5):1193-202. PubMed ID: 7299396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The brain ganglioside pattern in presenile and senile dementia.
    Op Den Velde W; Hooghwinkel GJ
    J Am Geriatr Soc; 1975 Jul; 23(7):301-3. PubMed ID: 1141629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of mercury and copper with constitutive heterochromatin and euchromatin in vivo and in vitro.
    Bryan SE; Simons SJ; Vizard DL; Hardy KJ
    Biochemistry; 1976 Apr; 15(8):1667-76. PubMed ID: 1268189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromatin structure in dementia.
    McLachlan DR; Lewis PN; Lukiw WJ; Sima A; Bergeron C; De Boni U
    Ann Neurol; 1984 Apr; 15(4):329-34. PubMed ID: 6742779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease and senile brains: an immunofluorescence study.
    Licandro A; Ferla S; Tavolato B
    Riv Patol Nerv Ment; 1983; 104(2):75-87. PubMed ID: 6387867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA binding protein profiles in Alzheimer's disease.
    Wetmur JG; Casals J; Elizan TS
    J Neurol Sci; 1984; 66(2-3):201-8. PubMed ID: 6543372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced intraneuronal lipofuscin content in dementia with Lewy bodies compared with Alzheimer's disease and controls.
    Drach LM; Bohl J; Wach S; Schlote W; Goebel HH
    Dement Geriatr Cogn Disord; 1998; 9(1):1-5. PubMed ID: 9469257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aluminum, altered transcription, and the pathogenesis of Alzheimer's disease.
    Crapper McLachlan DR; Lukiw WJ; Kruck TP
    Environ Geochem Health; 1990 Mar; 12(1-2):103-14. PubMed ID: 24202576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in protein synthetic capability of nerve cells in Alzheimer's disease.
    Mann DM; Neary D; Yates PO; Lincoln J; Snowden JS; Stanworth P
    J Neurol Neurosurg Psychiatry; 1981 Feb; 44(2):97-102. PubMed ID: 6163842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine in Alzheimer's disease and senile dementia.
    Yates CM; Allison Y; Simpson J; Maloney AF; Gordon A
    Lancet; 1979 Oct; 2(8147):851-2. PubMed ID: 90944
    [No Abstract]   [Full Text] [Related]  

  • 13. [Alterations in neurotransmitter in multi-infarct dementia and senile dementia of alzheimer's type (author's transl)].
    Miyata S; Yamao S; Nakamura S; Udaka F; Kameyama M
    Rinsho Shinkeigaku; 1981 Jun; 21(6):491-7. PubMed ID: 6117387
    [No Abstract]   [Full Text] [Related]  

  • 14. Aluminum levels in brain in Alzheimer's disease.
    Trapp GA; Miner GD; Zimmerman RL; Mastri AR; Heston LL
    Biol Psychiatry; 1978 Dec; 13(6):709-18. PubMed ID: 737258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
    Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
    Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.
    Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M
    Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease?
    Katsel P; Li C; Haroutunian V
    Neurochem Res; 2007; 32(4-5):845-56. PubMed ID: 17342407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcholinesterase and butyrylcholinesterase activities in cerebrospinal fluid from different levels of the neuraxis of patients with dementia of the Alzheimer type.
    Appleyard ME; McDonald B
    J Neurol Neurosurg Psychiatry; 1992 Nov; 55(11):1074-8. PubMed ID: 1469405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Approach to the dementia research].
    Tomonaga M
    Rinsho Shinkeigaku; 1989 Dec; 29(12):1532-5. PubMed ID: 2698299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fractionation and characterization of euchromatin isolated from mouse ascites sarcoma cells.
    Inaba K; Tanaka T; Oda T
    Acta Med Okayama; 1978 Dec; 32(6):399-405. PubMed ID: 154825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.